Tute Genomics
Total Raised
$8.59MInvestors Count
11Deal Terms
1Funding, Valuation & Revenue
7 Fundings
Tute Genomics has raised $8.59M over 7 rounds.
Tute Genomics's latest funding round was a Acquired for on October 12, 2016.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/12/2016 | Acquired | 4 | ||||
11/2/2015 | Unattributed | |||||
6/16/2015 | Series A - II | |||||
12/4/2014 | Series A | |||||
12/31/2013 | Angel |
Date | 10/12/2016 | 11/2/2015 | 6/16/2015 | 12/4/2014 | 12/31/2013 |
|---|---|---|---|---|---|
Round | Acquired | Unattributed | Series A - II | Series A | Angel |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
Tute Genomics Deal Terms
1 Deal Term
Tute Genomics's deal structure is available for 1 funding round, including their Series A from December 04, 2014.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Tute Genomics Investors
11 Investors
Tute Genomics has 11 investors. PierianDx invested in Tute Genomics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/12/2016 | 10/12/2016 | 1 Acquired | Corporation | Missouri | ||
6/16/2015 | 6/16/2015 | Healthbox | 1 Series A - II | Incubator/Accelerator | Illinois | |
6/16/2015 | 6/16/2015 | Intermountain Health | 1 Series A - II | Non-Profit Foundation | Utah | |
Corporation | China | |||||
Venture Capital | Utah |
First funding | 10/12/2016 | 6/16/2015 | 6/16/2015 | ||
|---|---|---|---|---|---|
Last Funding | 10/12/2016 | 6/16/2015 | 6/16/2015 | ||
Investor | Healthbox | Intermountain Health | |||
Rounds | 1 Acquired | 1 Series A - II | 1 Series A - II | ||
Board Seats | |||||
Type | Corporation | Incubator/Accelerator | Non-Profit Foundation | Corporation | Venture Capital |
Location | Missouri | Illinois | Utah | China | Utah |
Tute Genomics Acquisitions
1 Acquisition
Tute Genomics acquired 1 company. Their latest acquisition was Knome on November 02, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
11/2/2015 | Series C | $30.8M | Acquired | 2 |
Date | 11/2/2015 |
|---|---|
Investment Stage | Series C |
Companies | |
Valuation | |
Total Funding | $30.8M |
Note | Acquired |
Sources | 2 |
Loading...